Success story | Portfolio consolidation and governance in the pharmaceutical industry

Portfolio consolidation and governance in the pharmaceutical industry

CHALLENGES

Our client, a pharmaceutical company, faced difficulties to reach its objectives of new product launch and product changes delivery. These difficulties were partly due to the lack of portfolio management, in a context of high volume of projects and limited resources.

CYLAD was mandated to :

• Consolidate, characterize and rationalize the portfolio of all ongoing and future projects
• Develop an optimized portfolio management system

SOLUTIONS

For the portfolio consolidation, CYLAD :

• structured the portfolio architecture based on project triggers and types
• defined the attributes necessary to facilitate selection and prioritization (e.g. value, risk)
• consolidated all ongoing or forecasted projects within the organization, in a robust shared baseline

Simultaneously, CYLAD defined the portfolio management system:

• Definition and sizing of the organization around newly created Portfolio Manager position, with clear roles and responsibilities
• Demand management & steering processes, methods, routines and rules for portfolio governance, including project in-flow, monitoring, workload/capacity management and arbitration.

KEY DELIVERABLES

• Optimized consolidated portfolio baseline
• Evaluation matrix
• Portfolio management handbook

CUSTOMER BENEFITS

• SHARED SINGLE SOURCE OF TRUTH : Exhaustive project list/portfolio baseline
• PRIORIZATION RULES FOR RESOURCE ALLOCATION of portfolio pipeline based on value/effort analysis
• TEAMS ENGAGED thanks to clear organization and management system

Download PDF